PharMEDium Services Issues Voluntary Nationwide Recall of Specific Lots of Potassium Phosphate and Succinylcholine Chloride Due to a Lack of Sterility Assurance

PharMEDium Services is conducting a limited, voluntary recall due to Hospira Inc. ’s (“Hospira”) June 15, 2017 recall announcement that microbial growth was detected during a routine simulation of the manufacturing process and therefore there was a lack of sterility assurance. The products being recalled by PharMEDium Services were compounded using certain Hospira products.

Source: FDA Center for Drug Evaluation and Research - What's New - May 22, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news